Taiwan-based United Biomedical Inc. (UBI) Asia on Monday said it will file an appeal with the Taiwan Food and Drug Administration (FDA) after its request for emergency use authorization (EUA) for its COVID-19 vaccine was denied.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
12/08/2025 10:22 AM - Business
U.S. dollar lower in Taipei trading
12/08/2025 10:14 AM - Business
Taiwan shares open higher
12/08/2025 09:08 AM - Society
Taipei rally voices migrant workers' anger over work-year limit
12/07/2025 09:34 PM - Society
U.S. vaccine rollback 'regressive,' requires Taiwan vigilance: Expert
12/07/2025 09:15 PM